Today Lifebit Biotech announced it is providing its premium Lifebit CloudOS license free to all researchers and teams working on COVID-19 efforts, including diagnostics, treatments, and vaccines. As increasing demand for widely accessible reference data and massive data sharing has never been more apparent, this initiative provides researchers with a seamless way to perform their analyses securely, while enabling teams to freely collaborate even when working from home.
The end-to-end fully federated Lifebit CloudOS operating system is specifically engineered for life sciences data access, collaboration, and analysis. By bringing compute-to-data no matter where the data resides, and by accessing the platform’s powerful tools, researchers are able to arrive at actionable insights faster than ever before.
At this pivotal moment in history, scientists are working around the clock in the fight against COVID-19, and in many cases they are doing so while isolated at home,” said Dr Maria Chatzou Dunford, Lifebit CEO. “By making Lifebit CloudOS Team license free of charge to them, we are empowering these professionals with the technology they need to share and analyze all available data in the cloud, so that ultimately cures, treatments and vaccines can be rapidly developed.”
The Lifebit CloudOS Team license provides a team workspace for seamless collaboration and project sharing. Users can manage data, projects, access privileges, spending limits, reports, and more with advanced tools. Users also have access to the complete Lifebit CloudOS Marketplace and powerful APIs.
To further accelerate progress and help researchers save time in combating COVID-19, Lifebit also announced it has made globally available the dataset for SARS-CoV-2 from NCBI. The dataset consists of viral sequence data for SARS-CoV-2 and includes all Next Generation Sequencing runs for SARS-CoV-2 from SRA, associated metadata, and the virus reference genome. Learn more here.
COVID-19 researchers can register immediately for Lifebit CloudOS.
